Adial Pharmaceuticals, Inc. Discontinued Operation, Tax Effect of Discontinued Operation
Adial Pharmaceuticals, Inc. (ADIL) reported Discontinued Operation, Tax Effect of Discontinued Operation of $37.28 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2023-11-14
- Adial Pharmaceuticals, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-09-30 was $37.28K, a 93.32% decline year-over-year.
- Adial Pharmaceuticals, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-06-30 was -$2.60M, a 525.39% decline year-over-year.
- Adial Pharmaceuticals, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2022-09-30 was $558.20K.
- Adial Pharmaceuticals, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2022-06-30 was $610.65K.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month |
|---|---|---|---|
| 2023-09-30 | $37.28K 10-Q · filed 2023-11-14 | -$2.56M derived: sum of 2 quarters · filed 2023-11-14 | -$1.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$2.60M 10-Q/A · filed 2023-10-30 | -$1.93M 10-Q/A · filed 2023-10-30 | |
| 2022-09-30 | $558.20K 10-Q · filed 2023-11-14 | $1.17M derived: sum of 2 quarters · filed 2023-11-14 | $1.62M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $610.65K 10-Q/A · filed 2023-10-30 | $1.06M 10-Q/A · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |